IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 136 filers reported holding IMMUNOMEDICS INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $58,000 | +544.4% | 682 | 0.0% | 0.01% | +500.0% |
| Q1 2020 | $9,000 | -35.7% | 682 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | +55.6% | 682 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | 0.0% | 682 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $9,000 | – | 682 | +4446.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 15 | -95.6% | 0.00% | -100.0% |
| Q4 2018 | $5,000 | – | 339 | +2160.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 15 | -100.0% | 0.00% | -100.0% |
| Q1 2018 | $1,834,000 | -6.5% | 125,550 | +3.5% | 0.39% | -53.8% |
| Q4 2017 | $1,961,000 | +51.1% | 121,350 | +9.6% | 0.84% | +132.1% |
| Q3 2017 | $1,298,000 | -99.9% | 110,750 | +6.8% | 0.36% | +61.2% |
| Q2 2017 | $915,000,000 | +47.6% | 103,650 | -4.2% | 0.22% | +29.5% |
| Q1 2017 | $620,000,000 | +168.4% | 108,250 | +71.8% | 0.17% | +322.0% |
| Q4 2016 | $231,000,000 | +549900.0% | 63,000 | +384.6% | 0.04% | +412.5% |
| Q3 2016 | $42,000 | +40.0% | 13,000 | 0.0% | 0.01% | -20.0% |
| Q2 2016 | $30,000 | -6.2% | 13,000 | 0.0% | 0.01% | -9.1% |
| Q1 2016 | $32,000 | -17.9% | 13,000 | 0.0% | 0.01% | -26.7% |
| Q4 2015 | $39,000 | +77.3% | 13,000 | 0.0% | 0.02% | +87.5% |
| Q3 2015 | $22,000 | -38.9% | 13,000 | +44.4% | 0.01% | -33.3% |
| Q2 2015 | $36,000 | +5.9% | 9,000 | 0.0% | 0.01% | +9.1% |
| Q1 2015 | $34,000 | -20.9% | 9,000 | 0.0% | 0.01% | -21.4% |
| Q4 2014 | $43,000 | -20.4% | 9,000 | -37.9% | 0.01% | +27.3% |
| Q3 2014 | $54,000 | – | 14,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|